SONN
Sonnet BioTherapeutics
SONN
SONN
Delisted
SONN was delisted on the 2nd of December, 2025.
9 hedge funds and large institutions have $224K invested in Sonnet BioTherapeutics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.45% more ownership
Funds ownership: 5.25% → 5.7% (+0.45%)
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$17K | |
| 2 | +$8.13K | |
| 3 | +$109 | |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$7 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$4 |